Quick Answer
Imunon, Inc. reported Stockholders Equity of $7.06 million for the year ending 2025.
- Imunon, Inc. showed an increase of +66.4% in Stockholders Equity from 2024 to 2025.
- This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: -$5.04 million | Q2 2011: $489.4 thousand | Q3 2011: $18.26 million | Q1 2012: $20.36 million | Q2 2012: $14.58 million | Q3 2012: $13.02 million | Q1 2013: $32.30 million | Q2 2013: $32.99 million | Q3 2013: $29.14 million | Q1 2014: $40.56 million | Q2 2014: $45.36 million | Q3 2014: $38.92 million | Q1 2015: $26.70 million | Q2 2015: $29.11 million | Q3 2015: $25.08 million | Q1 2016: $15.31 million | Q2 2016: $16.51 million | Q1 2017: $6.11 million | Q2 2017: $6.65 million | Q3 2017: $5.29 million | Q1 2018: $23.61 million | Q2 2018: $19.15 million | Q3 2018: $15.13 million | Q1 2019: $21.40 million | Q2 2019: $18.83 million | Q3 2019: $15.46 million | Q1 2020: $16.21 million | Q2 2020: $24.21 million | Q3 2020: $18.66 million | Q1 2021: $54.96 million | Q2 2021: $64.05 million | Q3 2021: $59.34 million | Q1 2022: $46.27 million | Q2 2022: $47.04 million | Q3 2022: $41.35 million | Q1 2023: $26.65 million | Q2 2023: $21.52 million | Q3 2023: $18.07 million | Q1 2024: $8.50 million | Q2 2024: $3.74 million | Q3 2024: $8.19 million | Q1 2025: $452.0 thousand | Q2 2025: $2.66 million | Q3 2025: $4.08 million.
- Over the full 17 years of available data (2009 to 2025), Imunon, Inc.'s Stockholders Equity has declined by 29.6%.
- Historical annual values: Fiscal year 2025: $7.06 million | Fiscal year 2024: $4.24 million | Fiscal year 2023: $13.39 million | Fiscal year 2022: $29.33 million | Fiscal year 2021: $55.80 million | Fiscal year 2020: $18.61 million | Fiscal year 2019: $14.56 million | Fiscal year 2018: $20.86 million | Fiscal year 2017: $26.70 million | Fiscal year 2016: $6.73 million | Fiscal year 2015: $20.39 million | Fiscal year 2014: $32.83 million | Fiscal year 2013: $31.52 million | Fiscal year 2012: $11.96 million | Fiscal year 2011: $26.19 million | Fiscal year 2010: -$4.58 million | Fiscal year 2009: $10.04 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: